OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.480
+0.020 (1.37%)
At close: Aug 21, 2026, 4:00 PM EDT
1.480
0.00 (0.00%)
Pre-market: Aug 24, 2026, 4:00 AM EDT

OPKO Health Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
587.9606.88713.14863.51,0041,775
Revenue Growth
-11.46%-14.90%-17.41%-14.01%-43.42%23.64%
Gross Profit
115.4981.91113.3228.53214.33504.67
Operating Income
-167.89-218.99-272.36-158.06-246.12-14.46
Net Income
-72.89-225.68-53.22-188.86-328.41-30.14
Earnings Per Share
-0.09-0.30-0.08-0.25-0.46-0.05
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Diagnostics
313.07370.28480.67515.28755.631,607
Pharmaceutical
274.83236.6232.48348.22248.57167.61
Total
587.9606.88713.14863.51,0041,775

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
300.76364.41426.5895.88153.19134.71
Total Debt
398.08396.78504.44326.58305.74255.17
Net Cash (Debt)
-97.32-32.37-77.86-230.7-152.55-120.46
Net Cash Growth
------
Net Cash Per Share
-0.12-0.04-0.11-0.31-0.21-0.19

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-123.38-178.54-183.49-28.2-95.1938.34
Capital Expenditures
-10.64-12.28-25.01-16.28-24.58-32.16
Free Cash Flow
-134.02-190.82-208.5-44.47-119.776.18
Free Cash Flow Growth
-----6.68%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
19.64%13.50%15.89%26.47%21.34%28.44%
Operating Margin
-28.56%-36.08%-38.19%-18.30%-24.51%-0.81%
Pretax Margin
-13.58%-39.78%-1.46%-21.36%-39.03%-0.83%
Profit Margin
-12.40%-37.19%-7.46%-21.87%-32.70%-1.70%
FCF Margin
-22.80%-31.44%-29.24%-5.15%-11.93%0.35%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-88.0888.0888.0888.08103.61
P/FCF Ratio
-----530.03
PS Ratio
1.881.591.391.350.961.85